|
⚲
|
| Keyboard |
| Doberstein Stephen K
✚
|
|
|---|---|
| CIK # | 0001480111 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001480111] | |
| 4 | [0001480111] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tocagen Inc | |
| Doberstein Stephen K | |
| Dicerna Pharmaceuticals Inc | |
| Nektar Therapeutics |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2025-03-20 | Grant | 31,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2024-08-20 | Grant | 50,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2023-09-19 | Grant | 25,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2022-06-01 | Grant | 25,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2022-05-12 | Grant | 50,000 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2021-12-28 | Disposed to issuer | 25,000 | ||
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2021-12-28 | Tender | 3,333 | $38.25 | 127,487 |
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2021-12-28 | Disposed to issuer | 15,000 | ||
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2021-12-28 | Disposed to issuer | 15,000 | ||
|
Dicerna Pharmaceuticals Inc DRNA
Restricted Stock Units · derivative
|
2021-12-28 | Disposed to issuer | 3,333 | ||
|
Dicerna Pharmaceuticals Inc DRNA
Common Stock
|
2021-06-03 | Option exercise | 3,333 | ||
|
Dicerna Pharmaceuticals Inc DRNA
Restricted Stock Units · derivative
|
2021-06-03 | Option exercise | 3,333 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Restricted Stock Units · derivative
|
2021-06-03 | Grant | 3,333 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2021-06-03 | Grant | 15,000 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2020-06-15 | Grant | 15,000 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Restricted Stock Units · derivative
|
2020-06-15 | Grant | 3,333 | $0.00 | |
|
Dicerna Pharmaceuticals Inc DRNA
Director Stock Option (Right to Buy) · derivative
|
2020-03-12 | Grant | 25,000 | $0.00 | |
|
Nektar Therapeutics NKTR
Common Stock
|
2019-09-05 | Buy | 15,000 | $17.28 | 259,200 |
|
Nektar Therapeutics NKTR
Common Stock
|
2019-08-16 | Sell | 3,245 | $18.15 | 58,897 |
|
Nektar Therapeutics NKTR
Common Stock
|
2019-05-16 | Sell | 3,461 | $31.37 | 108,572 |
| showing 20 of 85 most recent transactions | |||||